Clinical trials for Lung cancer

300 currently recruiting clinical trials
Not Applicable Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer #NCT05878782
Required disease stage
Localized
1 recruiting site
Assistance Publique - Hôpitaux de Paris
Not Applicable Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Lymphoma CLL & Richter's syndrome Ovarian / Fallopian tubes / Peritoneum cancer Acute leukemia Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) Small intestine and appendix cancer Thyroid and adrenal gland cancer Amyloidosis Multiple myeloma Chronic myeloid leukemia (CML) Brain tumors / Central nervous system tumors Skin cancer #NCT02884375
2 recruiting sites
Assistance Publique - Hôpitaux de Paris
Not Applicable Lung cancer #NCT01993498
Cohorte poumon
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Surgery
2 recruiting sites
UNICANCER
Not Applicable Lung cancer #NCT04109131
Cohorte 3 CBNPC
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Metastatic
6 recruiting sites
Institut Jules Bordet
Not Applicable Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer Thyroid and adrenal gland cancer Brain tumors / Central nervous system tumors Skin cancer #NCT05354765
Cohortes A et B
Required previous treatments
Immunotherapy Bispecific T-cell engager antibodies
Required previous treatments at advanced or metastatic stage
Immunotherapy Car-T Bispecific T-cell engager antibodies
2 recruiting sites
Institut Curie
Not Applicable Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer Thyroid and adrenal gland cancer Skin cancer #NCT04109131
Cohorte 7 Carcinomatose leptoméningée
Required disease stage
Metastatic
6 recruiting sites
Institut Jules Bordet
Not Applicable Lung cancer #NCT04109131
Cohorte 4 CBPC
Required histologic types
SCLC (Small Cell Lung Cancer)
Required disease stage
Metastatic
6 recruiting sites
Institut Jules Bordet
Not Applicable Lung cancer #NCT04790682
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
ALK EGFR
3 recruiting sites
Institut Curie
Not Applicable Lung cancer #NCT06053099
Single Cohort
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Localized
Required genetic anomalies
EGFR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive Surgery
37 recruiting sites
Intergroupe Francophone de Cancérologie Thoracique